Plasma Methoxytyramine: A Novel Biomarker of Metastatic Pheochromocytoma and Paraganglioma in Relation to Established Risk Factors of Tumour Size, Location and SDHB Mutation Status
European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2011.07.016
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2012
Authors
Publisher
Elsevier BV